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ess: juniper@qoltech.coSummary The 7-item Asthma Control Questionnaire (ACQ) has been validated to
measure the goals of asthma management as defined by international guidelines
(minimisation of day- and night-time symptoms, activity limitation, b2-agonist use
and bronchoconstriction). Responses are given on a 7-point scale and the overall
score is the mean of the responses (0 ¼ totally controlled, 6 ¼ severely uncon-
trolled). The aim of this analysis was to determine the cut-point on the ACQ that
best differentiates between ‘well-controlled’ and ‘not well-controlled’ for (a)
clinical practice (low risk of missing ‘not well-controlled’) and (b) clinical trials (low
risk of including ‘well-controlled’). All 1323 patients who provided data sets at week
12 in the Gaining Optimal Asthma Control (GOAL) clinical trial were included in the
analysis. The gold standard for ‘well-controlled’ was a composite based on the GINA/
NIH guidelines and derived from data collected in the clinical trial diaries and clinic
records. The analysis showed that the crossover point between ‘well-controlled’ and
‘not well-controlled’ is close to 1.00 on the ACQ. However, to be confident that a
patient has well-controlled asthma, the optimal cut-point is 0.75 (negative
predictive value ¼ 0.85). To be confident that the patient has inadequately
controlled asthma, the optimal cut-point is 1.50 (positive predictive value ¼ 0.88).
In conclusion, knowledge of these cut-points will enhance practising clinicians ability
to identify patients whose asthma requires additional treatment, enable investiga-
tors to enroll poorly controlled patients into studies and for both clinicians and
investigators to evaluate whether treatment goals are being achieved.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
Fields, Bosham, West Sussex PO18 8NA, UK. Tel.: +44 1243 572124; fax: +44 1243 573680.
.uk (E.F. Juniper).
ARTICLE IN PRESS
Asthma Control Questionnaire cut points 617Introduction
The Asthma Control Questionnaire (ACQ)1 was
developed to measure the primary goals of asthma
management as identified by international guide-
lines.2–5 All guidelines indicate that to achieve good
control, treatment should minimise day- and night-
time symptoms, activity limitation, airway narrow-
ing and rescue bronchodilator use and thus reduce
the risk of life-threatening exacerbations and long-
term morbidity. Three independent studies have
provided evidence that the ACQ is valid for
measuring asthma control and has strong measure-
ment properties for use both in clinical practice
and research.1,6,7 In addition, the smallest change
in score that can be considered clinically important
has been determined.6
The aim of this analysis was to determine the
cut-points on the ACQ that give the best definition
between adequate and inadequate control. In
clinical practice it is important not to miss patients
whose asthma is inadequately controlled whereas
in clinical trials investigators usually want to enrol
patients with poorly controlled asthma which can
benefit from an intervention. Therefore, there
cannot be a single cut-point to serve all purposes.
In this study, we have used the database generated
by the Gaining Optimal Asthma Control (GOAL)
clinical trial8 to determine the probabilities of
patients having well- or not well-controlled asthma
for different cut-points of the ACQ. Although it is
considered most beneficial to use the full 7-item
ACQ for clinical practice, shorter 6- and 5-item
versions have been validated for use in clinical
trials and epidemiological surveys.6,7,9 In addition,
some clinical practices use the shorter versions
either because they are unable to measure airway
calibre or because some patients do not use an
inhaled short-acting b2-agonist as rescue medica-
tion. In this study we have examined whether the
cut-points for control are similar in all versions.Methods
Patients
This analysis was conducted using data collected
during the GOAL clinical trial. A full description of
the study design and patients has been published
elsewhere.7 In brief 3421 patients, 12–80 years,
with uncontrolled asthma were randomised to
either to fluticasone propionate or salmeterol/
fluticasone for 1 year. Patients with diary, clinic andACQ data at week 12 post-randomisation were
included in this analysis.Outcome measures
Asthma control questionnaire
Ninety-one asthma clinicians, who were members
of international asthma guideline committees,2–5
participated in the development of the ACQ.1 They
identified the 7 items in the questionnaires as being
the most important for determining the adequacy
of asthma control. Patients are asked to recall their
experiences during the previous week and to
respond to the first 6 questions (night-time waking,
symptoms on waking, activity limitation, shortness
of breath, wheeze and rescue short-acting b2-
agonist use) on a 7-point scale (0 ¼ no impairment;
6 ¼ maximum impairment). Clinic staff score FEV1%
predicted pre-bronchodilator on a similar 7-point
scale. The items are equally weighted and the ACQ
score is the mean of the 7 items and therefore
between 0 (totally controlled) and 6 (severely
uncontrolled). The ACQ has been validated and
has strong measurement properties for use in both
clinical practice and clinical trials.1,6,7Data for the gold standard
In a daily diary, patients scored the severity of day-
time and night-time asthma symptoms (0 ¼ none,
5 ¼ severe), amount of night-time awakening, daily
rescue b2-agonist use and morning peak expiratory
flow (PEF) rates. The clinic form recorded whether
patients experienced treatment-related adverse
events, exacerbations requiring oral corticosteroid,
emergency department visits and hospitalisation.Analysis
Gold standard
Patients who provided diary and clinic data at week
12 were categorised as having either ‘well-con-
trolled’ asthma (negative) or ‘not well-controlled’
asthma (positive) according to the definition shown
in Table 1. For patients who provided incomplete
diaries, the algorithm shown in Table 1 was used
for categorisation. Once patients had been
categorised, 2 2 tables were constructed for
cut-points of the ACQ at intervals of 0.25. For each
cut-point (from 0.25 upwards) the positive and
negative predictive values have been calculated.
An example of a 2 2 table and the calculation of
the predictive values are shown in Fig. 1.
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Table 1 Gold standard criteria for defining patients with ‘well-controlled’ asthma.
2 or more per week of:
(a) p2 days with symptom score 41
(b) rescue b2-agonist use on p2 days and p4 occasions
(c) PEF X80% predicted every day
And all of the following criteria
No night-time awakenings
No exacerbations (need for oral corticosteroids)
No emergency department visits/hospitalisations
No treatment-related adverse events enforcing a change in asthma therapy
Gold standard categorisation for diaries with missing data
Number of days of data available Classification
o7 days complete data+control criteria failed Not well-controlled
5–6 days complete data+control criteria achieved Well-controlled
o5 days complete data Excluded
Asthma Control 
Gold Standard
Positive = 
Not well-controlled 
Negative = 
Well-controlled 
Asthma Control 
Questionnaire 
Positive 
≥1.5 
394
a
55 
b 
Positive predictive value 
a/a+b = 394/449 =0.88
Negative
<1.5
c
297
d 
577
Negative predictive value 
d/c+d = 577/874 = 0.66
a = true positive ; b = false positive; c = false negative; d = true negative 
If a patient has an ACQ score  of 1.5 or greater, there is an 88% chance that their asthma is not well controlled. 
If a patient has an ACQ score of less than 1.5, there is a 66% chance that their asthma is well controlled 
Figure 1 Calculation of positive and negative predictive values for ACQ cut point of 1.5.
E.F. Juniper et al.618Positive predictive value (PPV): If a patient has a
score greater than the cut-point on the ACQ, the
PPV is the probability of the patient having ‘not
well-controlled asthma’.
Negative predictive value (NPV): If a patient has
a score less than the cut-point on the ACQ, the NPV
is the probability of the patient having ‘well-
controlled asthma’.Results
At week 12, 1323 patients of the 3421 randomised,
provided either complete data or diary/clinic data
to which the algorithm for missing gold standard
data could be applied. The majority of patientswere excluded because, at that time (2000), the
ACQ was not yet available in their language.
Positive and negative predictive values for
a range of cut-points on the ACQ are shown in
Tables 2–4. For all three versions of the ACQ, the
crossover point between well-controlled and not
well-controlled is close to 1.00. This means that
below 1.00 patients are more likely to have well-
controlled asthma and above 1.00 they are more
likely to have not well-controlled asthma. Con-
cordance at crossover was 0.76–0.77 for all 3
versions and therefore patients with a score close
to 1.00 can probably be considered borderline in
either direction.
If one is using the ACQ to identify patients whose
asthma is well-controlled (i.e. minimal risk of being
uncontrolled), a judicious cut-point is 0.75
ARTICLE IN PRESS
Table 3 Summary of 2 2 tables for the ACQ6 (no FEV1).
Asthma
control
questionnaire
cut points
Number of
true positives
(a)
Number of
false positives
(b)
Number of
false negatives
(c)
Number of
true negatives
(d)
Positive
predictive
value
Negative
predictive
value
0.25 676 424 15 208 0.61 0.93
0.5 625 264 66 368 0.7 0.84
0.75 589 193 102 439 0.75 0.81
1 486 102 205 530 0.83 0.72
1.25 429 82 262 550 0.84 0.68
1.5 325 46 366 586 0.87 0.62
1.75 295 25 396 607 0.92 0.61
2 212 11 479 621 0.95 0.56
2.25 171 7 520 625 0.96 0.54
2.5 110 6 581 626 0.94 0.52
Table 4 Summary of 2 2 tables for the ACQ5 (no FEV1 or bd).
Asthma
control
questionnaire
cut points
Number of
true positives
(a)
Number of
false positives
(b)
Number of
false negatives
(c)
Number of
true negatives
(d)
Positive
predictive
value
Negative
predictive
value
0.25 663 406 28 226 0.62 0.89
0.5 633 320 58 312 0.66 0.84
0.75 595 228 96 404 0.72 0.81
1 474 123 217 509 0.79 0.7
1.25 419 88 272 544 0.83 0.67
1.5 356 70 335 562 0.84 0.63
1.75 305 49 386 583 0.86 0.6
2 217 18 474 614 0.92 0.56
2.25 186 13 505 619 0.93 0.55
2.5 144 10 547 622 0.94 0.53
Table 2 Summary of 2 2 tables for the complete ACQ (7 items).
Asthma
control
questionnaire
cut points
Number of
true positives
(a)
Number of
false positives
(b)
Number of
false negatives
(c)
Number of
true negatives
(d)
Positive
predictive
value
Negative
predictive
value
0.25 686 522 5 110 0.57 0.96
0.5 665 375 26 257 0.64 0.91
0.75 621 235 70 397 0.73 0.85
1 525 146 166 486 0.78 0.75
1.25 486 107 205 525 0.82 0.72
1.5 394 55 297 577 0.88 0.66
1.75 297 23 394 609 0.93 0.61
2 225 10 466 622 0.96 0.57
2.25 190 8 501 624 0.96 0.55
2.5 125 3 566 629 0.98 0.53
a–d ¼ cells of the 2 2 tables (see Table 2).
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E.F. Juniper et al.620(NPV ¼ 0.85) (Table 2). This means that if a patient
has an ACQ score of 0.75 or less, there is an 85%
chance that his/her asthma is well-controlled.
If one is using the ACQ to identify patients whose
asthma is not well-controlled (i.e. minimal risk of
being well-controlled), a judicious cut-point is 1.50
(PPV ¼ 0.88). This means that if a patient has an
ACQ score of 1.50 or greater, there is an 88% chance
that his/her asthma is not well-controlled.
Very similar values were observed for the two
shortened versions of the ACQ (Tables 3 and 4).Discussion
This analysis has provided the positive and negative
predictive values for a range of cut-points on the 7-
point scale of the original ACQ and two shorter
versions. These values will enable users of the
questionnaire to know whether patients are likely
to have either well-controlled or not well-con-
trolled asthma as defined by the GINA guidelines.10
In clinical trials, investigators usually want to
enrol patients whose asthma is not well-controlled
so that there is room for improvement on the trial
intervention. Therefore, one wants a cut-point that
gives a high PPV (i.e. there is minimal risk of
enrolling patients with well-controlled asthma).
This means there may be some false negatives (i.e.
there are patients who are inadequately controlled
who are excluded from the study). If a patient has
an ACQ score of 1.50 or greater, there is an 88%
chance that his/her asthma is not well-controlled.
When the ACQ is used in clinical practice, we
usually want things the other way round. We want
to make sure that we do not miss patients whose
asthma is not well-controlled. One therefore needs
a cut-point that provides a high NPV which means
that there is a low risk of false negatives but
conversely there will be some false positives (i.e.
patients whose asthma is well-controlled but their
score suggests not well-controlled). To make sure
that most patients with inadequately controlled
asthma are not missed, the optimum cut-point is
0.75 where there is an 85% chance that his/her
asthma is well-controlled.
Although international guidelines2–5,10 indicate
that the ideal treatment goal in asthma should be
‘total control’ with patients having no symptoms,
no activity limitations, no rescue bronchodilator
use and normal airway calibre, a more realistic goal
is usually considered to be ‘well-controlled’ where
patients may experience occasional minor impair-
ments but are at minimal risk of exacerbation or
long term airway damage. Although there are
several definitions of well-controlled, the onechosen for the GOAL study was the one identified
by Bateman et al.11 as being the best to meet these
clinical goals. The authors and the other members
of the GOAL study committee identified the cut-
points on the outcomes collected in the study
(diary and clinic record) that should be used to
meet this definition.7 Therefore, a strength of this
gold standard was that it was based on objective
data rather than clinician impression.
Although a change in score of 0.5 on the ACQ can
be considered clinically important,6 the ultimate
goal of management is usually to achieve well-
controlled asthma. To be confident that a patient
has realised this state, it would be wise to use the
lower cut-point of 0.75 where 85% of patients will
be well-controlled. At the higher cut-point of 1.50,
the probability of having well-controlled asthma is
only 66%.
In this study, both the ACQ and the diary/clinic
record composite (gold standard) were developed
to measure the same construct, asthma control as
defined by international guidelines.2–5,10 However,
the correlation between the two instruments,
although acceptable for the task, was only modest
(r ¼ 0:76) and the possible reasons need to be
explored. Both instruments include night-time
waking, day-time symptoms, rescue bronchodilator
use and a measure of airway calibre. However, they
differ in that the ACQ includes activity limitation
(not in the composite) and the composite includes
medication side effects and ER/hospitalisations
(not in the ACQ). The ACQ has undergone several
validation studies (reliability, responsiveness and
construct validity) and shown strong measurement
properties,1,6,9 whereas the composite gold stan-
dard is considered valid by definition.
Other possible reasons for the lack of concor-
dance between the two instruments include: (1)
noise of measurement (both instruments), (2)
different scoring systems: ACQ is the mean of 7
items scored on 7-point interval scale (continuous
data): the gold standard is based on the total
number of dichotomous events (e.g. no. of days
with Sx41; no. of days witho1 puff bd), (3) the
ACQ is a clinic questionnaire and the composite
used diaries and clinic records, (4) some diaries had
missing data and an algorithm was used to estimate
control, (5) the ACQ uses FEV1% predicted (7-point
scale) and the composite uses PEF (780%
predicted).
Although it is important to identify possible
weaknesses, it is also important to recognise the
strengths of this analysis. There was a very large
sample and the majority of patients provided data
sets that could be included in the analysis. The gold
standard was estimated objectively which is very
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that clinicians may not be very good at giving a
subjective estimate of asthma control.12,13 Patients
represented a wide range of asthma severity and
therefore the results can be applied to all patients
with asthma. The modest correlation between the
two instruments, caused by the limitations men-
tioned above, will have only have affected the
precision of the estimate, they should not have
affected the accuracy. Therefore one can have
confidence that the actual crossover point is close
to 1.00.
In conclusion, knowledge of these cut-points will
enable investigators to enroll patients whose
asthma is poorly controlled into clinical trials, they
will enhance practising clinicians’ ability to identify
patients whose asthma requires additional treat-
ment and both investigators and clinicians will be
able to evaluate the effectiveness of interventions
by determining whether patients achieve the
threshold of well-controlled asthma.References
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